PROGNOSIS AND TREATMENT OF PRIMARY MEMBRANOUS NEPHROPATHY

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

BELADI MOUSAVI S.S.; CHITSAZIAN Z.

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Feyz Medical Sciences Journal Year:2013 | Volume:17 | Issue:4 Page(s): 400-407

Download Full-Text

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

View:

5,919

Download:

Cites:

Information Journal Paper

Title

PROGNOSIS AND TREATMENT OF PRIMARY MEMBRANOUS NEPHROPATHY

Author(s)

BELADI MOUSAVI S.S. | CHITSAZIAN Z. | Issue Writer Certificate

Keywords

MEMBRANOUS NEPHROPATHYQ2

NEPHROTIC SYNDROMEQ3

CYCLOPHOSPHAMIDEQ2

CYCLOSPORINEQ3

Abstract

Background: MEMBRANOUS NEPHROPATHY (MN) is the most common cause of the NEPHROTIC SYNDROME and renal failure in nondiabetic adults. The aim of this study was to evaluate the current diagnostic and therapeutic approaches for the disease.Materials and Methods: Epidemiology, pathogenesis, etiologies, natural course, differential diagnosis, treatment options, complications and follow up of the disease were all reviewed in this paper.Results: Most cases of MN are idiopathic, but it can be associated with autoimmune diseases, hepatitis B and C, malignancies, and the use of certain drugs. Spontaneous complete or partial remission of proteinuria occurred in 20 to 40 percent of patients with idiopathic MN. Thus, while almost all patients are candidates of conservative therapies for NEPHROTIC SYNDROME (eg, angiotensin inhibitors and statins for hyperlipidemia), immunosuppressive therapies include cytotoxic drugs (usually CYCLOPHOSPHAMIDE) plus glucocorticoids or a calcineurin inhibitor (cyclosporine or tacrolimus) with or without low dose glucocorticoids and ultimately treatment with rituximab should be considered for patients at high risk for a progressive renal failure.Conclusion: Early diagnosis and appropriate treatment, especially in high risk patients, may decrease the mortality/morbidity rate and renal failure associated with MEMBRANOUS NEPHROPATHY.

Cites

No record.

References

No record.

Cite

APA: Copy

BELADI MOUSAVI, S.S., & CHITSAZIAN, Z.. (2013). PROGNOSIS AND TREATMENT OF PRIMARY MEMBRANOUS NEPHROPATHY. FEYZ, 17(4), 400-407. SID. https://sid.ir/paper/40869/en

Vancouver: Copy

BELADI MOUSAVI S.S., CHITSAZIAN Z.. PROGNOSIS AND TREATMENT OF PRIMARY MEMBRANOUS NEPHROPATHY. FEYZ[Internet]. 2013;17(4):400-407. Available from: https://sid.ir/paper/40869/en

IEEE: Copy

S.S. BELADI MOUSAVI, and Z. CHITSAZIAN, “PROGNOSIS AND TREATMENT OF PRIMARY MEMBRANOUS NEPHROPATHY,” FEYZ, vol. 17, no. 4, pp. 400–407, 2013, [Online]. Available: https://sid.ir/paper/40869/en

Related Journal Papers